We could not miss the Innovation Forum – Economic Forum in Tarnów. Paweł Biernat and Konrad Krajewski participated in the conference attended by representatives of the scientific community, business world and politics. The event formula provides for panel discussions of experts in various fields and an opportunity for start-ups, the largest advisory companies, IT sector businesses and industrial […]

Gazeta Wrocławska: Carriers of active substances developed by Biotts can be used as a transport system for commonly used oncological, anti-inflammatory and analgesic drugs, increasing their targeted action by up to 10 times, whereas the drug dose can be reduced 5-fold, which radically mitigates side effects of therapy. The Company also develops proprietary drug formulas […]

Rynek Aptek: – In 2018, we managed to obtain funding from external investors and from grants amounting to the total of 3 million PLN, so now we can conduct research on three products. The first one is used for tissue regeneration, and the second one is an anaesthetic product offering an accelerated and prolonged anaesthetic […]

Newseria: – Our main product that we are currently focused on is a transdermal system that increases the bioavailability of active substances. First and foremost, it improves the patient’s comfort during therapy. Our daily tablet intake can be huge, and some patients have to take more than ten or even twenty tablets a day, so […]

MamStartup: Biotts, a company from Wrocław, has just received the “Lower Silesian Innovation Voucher” granted to enterprises to finance research services, consultations with scientific establishments and technology audits. Biotts is a Polish biotechnology company creating proprietary preparations and drug formulas based on extracts of natural origin, as well as proprietary carriers that increase the bioavailability […]

Our application under the “Lower Silesian Innovation Voucher” is successful. The grant under the programme is given to enterprises from Lower Silesia to finance research services, consultations with scientific establishments and technological audits. What is more, the scheme also finances R&D works on the implementation or development of products or technologies. We will use the […]